文献速递胸部肿瘤放疗放疗物理与技术

端粒长度动态作为接受胸部放疗肺癌患者个体放射敏感性与放射性肺炎的生物标志物

Telomere Length Dynamics as a Biomarker of Individual Radiation Sensitivity and Pneumonitis in Lung Cancer Patients Receiving Thoracic Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-01-14

该前瞻性研究在2019-2022年纳入接受胸部放疗的癌症患者,检测放疗前及放疗后≤12个月外周血单核细胞端粒长度及DNA修复能力,发现根治性放疗与端粒缩短相关,端粒长度动态变化在预测症状负担和放射性肺炎方面优于静态测量。

要点

  • 放疗前端粒长度随年龄和癌症分期增加而降低。
  • 根治性放疗与PBMCs端粒缩短相关,可在放疗后≤6个月检测到。
  • 端粒长度动态变化预测放疗不良结局优于静态测量。

核心结论

  • 淋巴细胞端粒长度可反映个体放射敏感性并与氧化损伤修复相互作用。
  • 纵向评估端粒长度动态变化较静态测量对放疗不良结局提供额外预测价值。

研究设计与样本

  • 前瞻性研究,2019-2022年在布莱根妇女医院纳入接受胸部放疗的癌症患者。
  • 放疗前及放疗后≤12个月采集外周血单核细胞,定量PCR测量端粒长度,荧光多重宿主细胞再激活试验评估多通路DNA修复能力。

主要发现

  • 放疗前端粒长度随年龄增长而降低(每年降低0.44%;95%CI 0.12%-0.77%)。
  • 放疗前端粒长度随癌症分期增加而降低(每增加一个分期降低6.87%;95%CI 3.45%-10.16%)。
  • 根治性放疗与PBMCs端粒缩短相关(降低3.7%;95%CI 0.27%-7.07%),可在放疗后≤6个月检测到。
  • 端粒长度与针对氧化损伤的DNA修复能力呈正相关,A:8-oxoG修复能力介导12.8%的放疗诱导端粒缩短。

临床怎么用

  • 端粒长度动态变化可能作为预测放射性肺炎和症状负担的生物标志物。
  • 需进一步研究以完全确定端粒长度的临床实用性。

局限性

  • 需进一步研究以完全确定端粒长度的临床实用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Telomere shortening is a biomarker for genome instability and aging, and the vulnerability of telomeric DNA to oxidative damage suggests its potential role in mediating radiation therapy (RT) side effects. This study evaluates telomere length (TL) as a biomarker for clinical radiosensitivity and adverse outcomes in thoracic RT-treated patients. METHODS AND MATERIALS: Patients with cancer receiving thoracic RT (2019-2022) were prospectively enrolled at Brigham and Women's Hospital, Boston, Massachusetts. Peripheral blood mononuclear cells (PBMCs) were collected pre-RT and ≤12 months post-RT. TL was measured using quantitative PCR, and multipathway DNA repair capacity (DRC) was simultaneously assessed by fluorescence multiplex host cell reactivation assays. RT outcomes included patient-reported quality of life and radiation pneumonitis. Linear mixed-effects models were used to analyze TL dynamics; risk prediction models for RT outcomes were evaluated using area under the curve. RESULTS: Pre-RT TL decreased with age (0.44% lower per year; 95% CI, 0.12%-0.77%) and advanced cancer stage (6.87% lower per step increase of stage; 95% CI, 3.45%-10.16%). Radical RT was associated with telomere shortening (3.7% lower; 95% CI, 0.27%-7.07%) in PBMCs, detectable ≤6 months post-RT. Pre-RT TL strongly predicted post-RT changes, and TL dynamics outperformed static measures in predicting symptom burden and radiation pneumonitis. Positive associations were observed between TL and DRC against oxidative lesions, with A:8-oxoG repair capacity mediating 12.8% of RT-induced TL shortening. CONCLUSIONS: Lymphocyte TL can reflect individual radiosensitivity and interact with oxidative damage repair. Longitudinal assessment of TL dynamics provides additional predictive value for adverse RT outcomes compared with static measures. Further studies are needed to fully determine the clinical utility of TL.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Zhai T, Toprani SM, Dillon-Martin M, et al. Telomere Length Dynamics as a Biomarker of Individual Radiation Sensitivity and Pneumonitis in Lung Cancer Patients Receiving Thoracic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2026. PMID: 41544677. doi:10.1016/j.ijrobp.2025.12.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。